Recent Episodes
-
Revolutionizing the Production of Biologics with Algae
Jun 4, 2025 – 37:52 -
Making Medicines for a World of People with Cancer
May 28, 2025 – 42:59 -
Harnessing Myeloid Cells to Attack Cancer
May 21, 2025 – 37:00 -
Drawing Lessons from the COVID Pandemic
May 14, 2025 – 32:05 -
A Bet that Myostatins Can Muscle Out Obesity
May 7, 2025 – 29:51 -
Making Whole-Eye Transplantation a Reality
Apr 30, 2025 – 25:04 -
Synbio Companies Come to Grips with the One “Omic” that Matters
Apr 23, 2025 – 34:38 -
Searching for Safer Pain Medications
Apr 16, 2025 – 39:19 -
Bridging the Translational Divide in Healthcare AI
Apr 9, 2025 – 27:45 -
Seeking Long-Term Pain Relief from a Drug-Free Injection
Apr 2, 2025 – 29:10 -
Engaging Hard-to-Target Receptors with Antibodies that Activate
Mar 26, 2025 – 39:43 -
An Insider’s View of the Patent Fights that Shaped the Biotech Industry
Mar 19, 2025 – 01:11:18 -
Restoring Balance to the Immune System in Allergic Diseases
Mar 12, 2025 – 28:36 -
Turning Natural Killers into Off-the-Shelf Therapies for Autoimmune Disease
Mar 5, 2025 – 32:09 -
Combining an Antibody and siRNA to Treat Hepatitis B
Feb 26, 2025 – 29:28 -
Looking at the Promise of GLP-1 Agonists Beyond Obesity
Feb 19, 2025 – 22:20 -
An Off-the-Shelf Cancer Vaccine Faces a Final Clinical Hurdle in NSCLC
Feb 12, 2025 – 31:20 -
A Nose for Attacking Brain Cancer
Feb 5, 2025 – 08:54 -
An Unnatural Approach to Undruggable Targets
Jan 29, 2025 – 24:52 -
Expanding the Drug Developer’s Chemical Universe
Jan 22, 2025 – 33:52 -
Take 100 Megabytes a Day and Call Me in the Morning
Jan 15, 2025 – 29:20 -
Extracting the Benefits of Psychedelics
Jan 8, 2025 – 34:25 -
A Magellan that Circumnavigates Active Binding Sites
Jan 1, 2025 – 37:40 -
A Very Meh-Ry Biotech Year and What’s Ahead in 2025
Dec 25, 2024 – 40:28 -
Using Light to Biomanufacture a Steak
Dec 18, 2024 – 33:43 -
Sit, Stay, and Heal: Bringing Precision Medicine to Dogs, then Humans
Dec 11, 2024 – 34:46 -
Targeting the Undruggable Proteome
Dec 4, 2024 – 32:31 -
Preventing a Deadly Disease by Detecting It Before It Becomes Cancer
Nov 26, 2024 – 36:44 -
Getting Tumors to Say “Eat Me”
Nov 20, 2024 – 25:08 -
Targeting the Dark Matter of the Genome to Treat Diseases
Nov 13, 2024 – 32:33 -
Using AI to Discover Small Molecule Alternatives to Biologics
Nov 6, 2024 – 31:33 -
A BET on a Novel Approach to Treat Autoimmune Conditions
Oct 30, 2024 – 24:40 -
Cell Therapies that Can Do a Solid for People with Cancer
Oct 23, 2024 – 51:49 -
Going to Extremes to Discover New Drugs
Oct 16, 2024 – 31:38 -
Targeting Senescent Cells to Treat Aging-Related Diseases
Oct 9, 2024 – 31:44 -
Bringing Cellular Diversity into Sharper Focus
Oct 2, 2024 – 30:35 -
Developing Cancer Therapies for When Damage Control Goes Awry
Sep 25, 2024 – 18:09 -
Delivering the Goods
Sep 25, 2024 – 36:06 -
Swimming in the New Oil
Sep 11, 2024 – 22:26 -
Does This Drug Represent “A Paradigm Shift for Small Molecule Drug Development?”
Sep 4, 2024 – 28:01 -
Exploring the Promise and Peril of CRISPR
Aug 28, 2024 – 57:36 -
Transforming Protein Engineering with Generative AI
Aug 21, 2024 – 35:47 -
Delivering Peptide Therapies Orally
Aug 14, 2024 – 34:06 -
Creating A Drug Delivery ARMMs Race
Aug 7, 2024 – 24:42 -
A Seek and Destroy Approach to Disease-Causing Proteins
Jul 31, 2024 – 37:10 -
Teaching Tolerance to Address Autoimmune Diseases
Jul 24, 2024 – 36:25 -
A Bet That the Next Blockbuster May Already Be Inside You
Jul 17, 2024 – 22:34 -
A Big Mac Attack to Fight Cancer
Jul 10, 2024 – 36:37 -
Getting Animated about Bioliteracy
Jul 3, 2024 – 24:29 -
Reshaping Clinical Trial Designs with Real-World Data
Jun 26, 2024 – 28:53
Recent Reviews
-
Snsn snsnsnPoor interviewing skillsIt is clear the host is just reading from a script. It’s very distracting the way he pauses in weird places in sentences. And then he essentially ignores what the guest is saying. No follow up questions, no listening, no semblance of conversation, just on to the next canned question. I suggest the host listens to his own interview with Kolluri—he rudely interrupts him several times, and for what reason? Simply to ask his next canned question! It’s so strange. It doesn’t sound like a big deal, but all of this is so distracting that it makes it difficult to focus on the content.
-
DanP9191Too loudThe content is interesting and it’s one of the podcasts I listen to most, but the advertisement and especially the jazz transition music is SO LOUD. When I’m driving and my hands are occupied, I actively cringe at the expectation of having my eardrums blasted when an episode begins or ends. When I’m not driving I try to skip ahead to the ~2 minute mark, because missing a bit of starting context from the actual show is worth preserving my hearing. Please make the audio levels consistent.
-
NotRecommended1Not for physiciansI’m a physician doing translational research in gene therapy. At least for the medical part the interviews discuss inaccurate information. For example there’s a talk where the interviewee says that in medicine therapy for most or all diseases are only symptom based “...such as diabetes and cancer...” which is absolutely wrong as especially in these diseases therapy starts as early as possible specifically to prevent symptoms. In addition there are some interviews where it seems that the members of the discussion haven’t discussed before hand what points will be touched and sometimes the interviewee “corrects the interviewer” which makes listening confusing. I’m unsubscribing and will search for other translational gene therapy research podcasts.
-
bman90254Paid for advertising?I can see the relevance for investors to hear these advertisements, however, as a scientist I fail to see the value.
-
DGrandeSound quality lacking, but great contentCan’t understand why this isn’t more popular...it’s incredibly relevant, instructive, and brings in great guests. These are the things I need to know for my team and company. 5 stars.
-
InraterGood contentI am a longtime investor in Biotech and find the topics and interviews extremely interesting. The sound is not that good but it really doesn’t matter when the content is interesting. I would shorten the intro jingle by 50%. Keep up the good work.
-
Crob9120Audio quality is horribleSounds like he just records the speaker phone audio...
-
PhelineCatCrushingly disappointingI particularly wanted to hear the episode for August 17, 2017- since Reagan there's been excessive focus on shareholders instead of long term company health and employee retention and morale across all industries- but the sound quality was terrible. I tried a few other episodes and I knew I wasn't going to get anything out of this pod because of the poor recording and editing. My suggestions- 1. Spend time learning to do a better job with what you have. There are mentors out there who understand you need knowledge first. 2. Add to your equipment slowly in an as needed basis. Buying the best won't help if you still don't know how to use it. That's the technical stuff but I can't address content. What I hope this podcast does is knock Reagan off his artificial pedestal of broken economic policies- people began suffering in uncounted ways and the stock market solidified that.
Similar Podcasts
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.